Kourie J I, Henry C L
Membrane Transport Group, Department of Chemistry, The Faculties, Building 33, Science Road, The Australian National University, Canberra City, ACT 0200, Australia.
Croat Med J. 2001 Aug;42(4):359-74.
Protein deposition, aggregation, and formation of amyloids are associated with a wide range of pathologies, including several neurodegenerative diseases. Aggregation and deposition are a result of malfunction in protein folding, assembly, and transport, caused by protein mutation and/or changes in the cell environment. The mechanism of protein deposition and aggregation is triggered when the hydrophobic and positively charged regions of the misfolded proteins are exposed. The cells aim to regulate these misfolded and malfunctioning aggregation-prone proteins by degradation mechanisms, e.g., proteosomes, and/or by storing them in specialized compartments, e.g., Russell bodies and aggresomes. During these processes, however, some aggregation-prone protein intermediates are capable of aggregation and forming beta-sheet based channels in various negatively charged cellular membranes. Adverse cellular conditions, transitional metals, cellular proteins, and genetic mutations play an important role in the formation and function of these non-intrinsic channels. These channels, which can damage membrane function, are pathologic because they can disrupt the metabolic, ionic, and water homeostasis and distort signal transduction. We propose that different conformations of aggregation-prone proteins could alter cell regulation by modifying several ion transport systems and also by forming heterogeneous ion channels. The changes in membrane transport systems are proposed as early steps in impairing neuronal function preceding fibril formation. We conclude that these changes damage the membrane by compromising its integrity and increasing its ion permeability. This mechanism of membrane damage is a general mechanism that may explain other malfunctioning protein processing-related pathologies.
蛋白质沉积、聚集以及淀粉样蛋白的形成与多种病理状况相关,包括几种神经退行性疾病。聚集和沉积是蛋白质折叠、组装及运输功能异常的结果,由蛋白质突变和/或细胞环境变化引起。当错误折叠蛋白质的疏水区域和带正电荷区域暴露时,蛋白质沉积和聚集的机制就会被触发。细胞旨在通过降解机制(如蛋白酶体)和/或通过将它们储存在特殊的区室(如拉塞尔小体和聚集体)中来调节这些错误折叠且易于聚集的功能异常蛋白质。然而,在这些过程中,一些易于聚集的蛋白质中间体能够聚集并在各种带负电荷的细胞膜中形成基于β-折叠的通道。不利的细胞条件、过渡金属、细胞蛋白质和基因突变在这些非固有通道的形成和功能中起重要作用。这些能够损害膜功能的通道是病理性的,因为它们会破坏代谢、离子和水平衡,并扭曲信号转导。我们提出,易于聚集的蛋白质的不同构象可通过改变几种离子转运系统以及通过形成异质离子通道来改变细胞调节。膜转运系统的变化被认为是原纤维形成之前损害神经元功能的早期步骤。我们得出结论,这些变化通过损害膜的完整性并增加其离子通透性来破坏膜。这种膜损伤机制是一种普遍机制,可能解释其他与蛋白质加工功能异常相关的病理状况。